Study: Resistant Infections Increase COVID-19 Patient Mortality
Hospitalized COVID-19 patients who develop infections involving resistant bacteria or fungi face substantially higher in-hospital mortality rates than those without additional infections, according to a retrospective cohort study published in BMC Infectious Diseases. The findings show that mortality reached 64.9% among patients with resistant bacterial infections and 60.9% for those with fungal involvement, compared to 22.1% for patients with no detected secondary infections.
-
Key Clinical Takeaways:
- Mortality rates among hospitalized COVID-19 patients rose sharply when secondary infections involved resistant pathogens or fungi, reaching up to 64.9%.
- Resistant Acinetobacter baumannii was the most frequently detected pathogen, appearing in 55.9% of patients with an infection.
- Invasive mechanical ventilation was significantly associated with the acquisition of secondary bacterial and fungal infections in intensive care settings.
Zhejiang University Hospital Study Tracks 428 Inpatients
The study reviewed medical records from the Second Affiliated Hospital of Zhejiang University School of Medicine. Researchers evaluated 428 adult COVID-19 inpatients with microbiological surveillance data admitted between November 2022 and February 2023. Out of that cohort, 333 patients, representing 77.8%, developed at least one additional infection during their hospital stay.
Investigators classified infections detected within 48 hours of admission as co-infections, while those detected after 48 hours were designated as secondary infections. Pathogens were grouped into Gram-negative bacteria, Gram-positive bacteria, and fungi, with resistant isolates identified separately.
Resistant Bacteria Drive Highest Mortality Rates
The research established a graded pattern across four distinct pathogen-detection trajectories. Mortality was lowest among patients with no detected infection at 22.1%, rising to 55.1% for those with sensitive bacterial infections, 60.9% for fungal involvement, and 64.9% for resistant bacteria.
Among infected individuals, resistant Acinetobacter baumannii was the most frequently detected pathogen, appearing in 55.9% of cases. Resistant Klebsiella pneumoniae followed at 38.4%, fungal involvement at 33.0%, and resistant Pseudomonas aeruginosa at 14.1%.
Compared with the uninfected group, all three infection trajectories remained associated with in-hospital death.
Mechanical Ventilation Increases Secondary Infection Risk
Parallel findings emerged from intensive care research which reviewed 314 critically ill COVID-19 patients admitted to the intensive care unit at King Fahd Hospital of the University in Saudi Arabia between March 2020 and September 2021. That retrospective review reported that 42.4% of patients developed secondary infections, with a secondary bacterial infection incidence of 32.5% and fungal incidence of 25.2%.
The Saudi Arabian study identified invasive mechanical ventilation as a primary risk factor significantly associated with the development of secondary bacterial infections, yielding an odds ratio of 17.702, and secondary fungal infections, with an odds ratio of 12.914. Mortality among patients with secondary infections in that cohort reached 69.2%.
Weakened Immunity Correlates with Secondary Infections
These individuals often exhibit elevated inflammatory cytokines and weakened cell-mediated immunity, indicated by lower CD4+ and CD8+ T cell counts.
The Zhejiang University study authors noted limitations. The single-center, retrospective design cannot establish direct causation between the secondary infections and excess mortality, as unmeasured confounding factors, illness severity differences, and surveillance practices may influence the results.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.